Objectives: The M-current is a low-threshold voltage-gated potassium current generated by Kv7 subunits that regulates neural excitation. It is important to note that M-current suppression, induced by activation of Gq-coupled neurotransmitter receptors, can dynamically regulate the threshold of action-potential firing and firing frequency. Here we sought to directly examine whether M-current suppression is involved in seizures and epileptogenesis. Methods: Kv7.2 knock-in mice lacking the key protein kinase C (PKC) phosphorylation acceptor site for M-current suppression were generated by introducing an alanine substitution at serine residue 559 of mouse Kv7.2, mKv7.2 (S559A). Basic electrophysiologic properties of the M-current between wildtype and Kv7.2(S559A) knock-in mice were analyzed in primary cultured neurons. Homozygous Kv7.2(S559A) knock-in mice were used to evaluate the protective effect of mutant Kv7.2 channel against chemoconvulsant-induced seizures. In addition, pilocarpine-induced neuronal damage and spontaneously recurrent seizures were evaluated after equivalent chemoconvulsant-induced status epilepticus was achieved by coadministration of the M-current-specific channel inhibitor, XE991. Result: Neurons from Kv7.2(S559A) knock-in mice showed normal basal M-currents. Knock-in mice displayed reduced M-current suppression when challenged by a muscarinic agonist, oxotremorine-M. Kv7.2(S559A) mice were resistant to chemoconvulsant-induced seizures with no mortality. Administration of XE991 transiently exacerbated seizures in knock-in mice equivalent to those of wild-type mice. Valproate, which disrupts neurotransmitter-induced M-current suppression, showed no additional anticonvulsant effect in Kv7.2(S559A) mice. After experiencing status epilepticus, Kv7.2(S559A) knock-in mice did not show seizureinduced cell death or spontaneous recurring seizures. Significance: This study provides evidence that neurotransmitter-induced suppression of M-current generated by Kv7.2-containing channels exacerbates behavioral seizures. In addition, prompt recovery of M-current after status epilepticus prevents subsequent neuronal death and the development of spontaneously recurrent seizures. Therefore, prompt restoration of M-current activity may have a therapeutic benefit for epilepsy.
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| INTRODUCTION
Kcnq genes encode subunits of the Kv7 potassium channel family (Kv7.1-7.5). Kv7.2-7.5 subunits constitute neuronal Kv7 channels while the Kv7.1 subunit is expressed in the heart and pancreatic beta cells. [1] [2] [3] Kv7.2, Kv7.3, and Kv7.5
subunits are widely expressed in various neuronal types in both central and peripheral nervous systems, which form channels that generate a noninactivating low-threshold voltage-gated potassium current known as the M-type potassium current or the M-current. [4] [5] [6] [7] Although persistent changes to Kv7 channel activity by genetic mutations of the human Kcnq2 gene are well known to be linked with various types of epilepsies, 8 the role of transient modulation of Kv7 channel activities in epilepsy is not well understood.
The physiologic role of basal M-current activity includes generating spike frequency adaptation 9 and setting the firing frequency of regularly firing neurons. 10 Another important physiologic role of neuronal Kv7 channels is inducing transient increase in neuronal excitability in response to various neurotransmitters through M-current suppression, most notably by activation of muscarinic acetylcholine receptors (m1 or m3). 11, 12 Despite clear demonstrations of increase in neuronal excitability in vitro by M-current suppression, the physiologic and pathologic roles of M-current suppression in vivo are not well understood. The major reason for this is that the regulatory mechanism of M-current suppression remained elusive until recently. Accumulating evidence suggests that the loss of phosphatidylinositol 4,5-bisphosphate (PIP2) from Kv7 subunits induces M-current suppression 13, 14 because it is an essential cofactor for ion conduction. 15 Loss of PIP2 from Kv7.2 subunit can be achieved by 2 mechanisms: depletion of PIP2 by phospholipase C 16 or reduction in PIP2 affinity at the Kv7.2 subunit. 14 In the latter mechanism, it has been shown that protein kinase C (PKC)-mediated phosphorylation at serine 541 in rat Kv7.2 subunit, 17, 18 which corresponds to 559 for mouse and 558
for human orthologues, dissociates calmodulin from the Kv7.2 channel complex, thereby lowering affinity of Kv7.2 subunit to PIP2 ( Figure 1A ). 14 When this key PKC phospho-acceptor serine residue in the Kv7.2 subunit is mutated to alanine, neurotransmitterinduced M-current suppression is drastically attenuated. 14, 17 We recently demonstrated that valproate (VPA) treatment disrupts M-current suppression and observed that resultant preserved M-current contributes to the anticonvulsant action of VPA. 19 In support of neurotransmitter-mediated M-current suppression during seizures, microdialysis studies have shown that several neurotransmitters, including acetylcholine, become elevated during and after seizures. 20, 21 Therefore, M-current suppression during seizure episodes might be part of the seizure pathophysiology.
To address the role of M-current suppression in seizures, we generated a knock-in mouse line lacking the key PKC phosphorylation site mentioned earlier in the mouse Kcnq2 gene, mKv7.2(S559A). In this study, we analyzed wild-type and homozygous Kv7.2(S559A) mice to elucidate whether M-current suppression exacerbates seizures and contributes to status epilepticus-induced epileptogenesis in adult animals.
| MATERIALS AND METHODS

| Generation of Kv7.2(S559A) mice
Residue numbers in the mouse Kv7.2 protein in this article are based on the sequence of mouse Kcnq2, transcript variant 1 (NM_010611.3). Generation of the targeting vector was performed at BAC Recombineering Core, Duke Comprehensive Cancer Center (Duke University). The mutated sequence for Kcnq2 (S559A) is as follows: gcgaaagttcaaagagGCCctgcgcc catatg (capital letters correspond to the mutated alanine residue). Homologous recombination of the targeting vector was performed at the UC Irvine Transgenic Mouse Facility using a C57BL/6NTac derived embryonic stem cell line (JM8.N4). Homologous recombination was confirmed by Southern blots. Resultant chimeric mice were then crossed with C57BL/6-Tg(Zp3-cre)93Knw/j (Jackson Laboratory, Bar Harbor, Maine) to generate global knock-in mice. Excision of the neo cassette was confirmed by genomic polymerase chain
Key Points
• M-current suppression during seizures exacerbated behavioral seizures • Disrupting M-current suppression prevented mortality in pilocarpine-or kainate-induced seizures • M-current suppression after status epilepticus contributed to subsequent neuronal death • Disrupting M-current suppression after status epilepticus prevented epileptogenesis reaction (PCR; Figure S1 ). Generated knock-in mice were backcrossed to C57BL/6J mice for 6 generations. All recombinant DNA experiments were approved by the Institutional Biosafety Committee at UC Irvine. All animal experimental procedures were approved by The Institutional Animal Care and Use Committee at UC Irvine.
| Cell culture and electrophysiology
Neuron isolation and primary neuron culture were performed according to the protocol described previously 22 with some modifications. Briefly, cortical neurons were collected from forebrains of neonatal mice (postnatal day 0), dispersed by papain (2.5 mg/mL) and DNase (100 μg/mL), and plated onto poly-D-lysine-coated 35 mm dishes at 8 × 10 5 to 1 × 10 6 cells per dish. Neurons were maintained in a Neurobasal A medium containing B27, Glutamax, and 5 μmol/L AraC (Thermo Fisher Scientific, Waltham, Massachusetts) and cultured in vitro for 16-18 days before experiments. Superior cervical ganglion (SCG) neurons were prepared from 3-week-old mice and cultured for 2-4 days as described.
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Perforated patch-clamp recordings were performed at room temperature on isolated primary neurons using an Axopatch 200B patch-clamp amplifier (Molecular Devices, Sunnyvale, California) as described. 19 Signals were sampled at 2 kHz, filtered at 1 kHz, and acquired using pClamp software (version 10; Molecular Devices). The perforated patch-clamp method with amphotericin B was used to record macroscopic currents as described previously. Hyperpolarizing 500-msec step pulses to −50 mV from a holding potential of −30 mV with 10-second intervals were used to measure the M-current. Amplitudes of the M-currents were measured as XE991-sensitive standing current at −30 mV for cortical neurons. After establishing stable current recording for more than 2 minutes, 0.3 μmol/L oxo-M was applied for 2 minutes, followed by 10 μmol/L XE991 to assess M-current suppression as well as achieve complete inhibition of the M-current. For SCG neurons, deactivating currents during −50 mV step hyperpolarization were measured as the M-current as described. 19 The dose-response curve was fit using an equation
, where I min is the resistant fraction of the M-current, IC 50 is the half inhibition concentration, and [oxo-M] is the concentration of oxo-M.
| Chemoconvulsant-induced seizures
Two-month-old to 3-month-old C57BL/6 and homozygous Kv7.2(S559A) knock-in mice of both sexes were used. For pilocarpine-induced seizure experiments, methyl scopolamine (1 mg/kg, ip) was administered 15 minutes before injecting pilocarpine (289 mg/kg, ip). 24 Thirty minutes after pilocarpine administration, mice were injected with either 2 mg/kg XE991 (ip) in Dulbecco's phosphate-buffered saline (DPBS), or DPBS alone in indicated experiments. 24 Mice were videotaped for the subsequent 2 hours after pilocarpine injection, and behavior was scored by treatment and genotype-blinded observers every 10 minutes according to a modified Racine scale with the following criteria: stage 1-immobility and facial twitching; stage 2-head bobbing, Straub tail, "wet dog shakes"; stage 3-unilateral forelimb myoclonus; stage 4-bilateral forelimb myoclonus, rearing; and stage 5-total loss of balance, generalized convulsions. Animals that died during the experiments were assigned stage 5 thereafter. Status epilepticus was defined as behavioral seizures that reached stage 5 within the 2-hour observation period with at least 2 additional incidences of stage 4-5 seizures. For seizure survival experiments, mice were administered diazepam (5 mg/kg, ip) 2 hours after pilocarpine injection to terminate seizures and were given 5% glucose infusions until body weight was stabilized to correct dehydration. For kainate-induced seizure experiments, mice were injected with kainate subcutaneously at indicated doses. One hour after kainate administration, either 2 mg/kg XE991 in DPBS, or DPBS alone were injected (sc) in indicated experiments. For VPA experiments, adult mice were administered either freshly prepared sodium VPA (250 mg/ kg, VPA. ip) or physiologic saline solution twice daily for 3.5 days. 19 Kainate was administered at least 6 hours after the final VPA administration. To evaluate behavioral seizures, mice were videotaped for the subsequent 4 hours after kainate injection, and behavior was scored by treatment and genotype-blinded observers every 10 minutes according to a previously described modified Racine scale 19 with the following criteria: stage 1-immobility; stage 2-rigidity; stage 3-automatisms with scratching, head bobbing and circling; stage 4-intermittent rearing and falling; stage 5-continuous rearing and falling; and stage 6-tonic-clonic whole-body convulsions and rapid jumping. All mice that died during the experiments were assigned stage 6 thereafter.
| Spontaneously recurrent seizures
Pilocarpine-experienced wild-type and Kv7.2(S559A) mice that underwent status epilepticus were selected for observing the development of spontaneous ictal activity. Three weeks after induction of status epilepticus, animals were videotaped for 3 h/d for 15 days and observed by a treatment and genotype-blinded observer. Episodes with ≥ stage 4 seizure were considered to have a seizure and the frequency of ictal activity was logged.
| Immunohistochemistry
Immunohistochemistry protocol was followed as previously described. 19 Two hours after injection of pilocarpine, deeply anesthetized mice were fixed with 4% paraformaldehyde perfusion. c-Fos expression was detected using a rabbit anti-cFos antibody (1:1000 dilution, Cat No. PC38; Calbiochem, Burlington, Massachusetts). GAD67 was detected by anti-GAD67 antibody (1:5000 dilution, Cat. No. MAR5406; EMD Millipore, Burlingame, Massachusetts). VECTASHIELD with DAPI (Vector Laboratories Burlingame, California) was used for mounting. Immunofluorescent images were acquired using a fluorescent light microscope (Leica Microsystems, Buffalo Grove, Illinois, DM4000B) equipped with a CCD camera (Optronics, Goleta, California, MicroFire). Fluorescent images were quantified by observers blind to genotype and treatment using MetaMorph (Molecular Devices). Degenerating neurons were labeled by incubation with 0.0001% Fluoro Jade C (FJC; Cat. No. 1FJC; Histo-Chem Inc., Jefferson, Arkansas) dissolved in 0.1% acetic acid for 20 minutes. FJC images of whole sections were generated using a fluorescent light microscope (Keyence, Osaka, Japan).
| Statistics
All results are expressed as the mean ± standard error of the mean (SEM). Statistical significance of the results was assessed by nonparametric analysis of variance (Kruskal-
| RESULTS
| Noninactivating currents in neurons from Kv7.2(S559A) mice
We introduced an alanine substitution at the key PKC phosphorylation site 17 in the mouse Kcnq2 gene (Figure 1A ), Kv7.2(S559A), and generated Kv7.2(S559A) knock-in mice.
The residue at this phosphorylation site is conserved throughout the Kv7 subfamily except for the nonneuronal Kv7.1 subunit. Homologous recombination in embryonic stem cells was confirmed by Southern blotting ( Figure S1 ). In clear contrast to global Kcnq2 knock-out mice that are neonatal lethal due to pulmonary atelectasis 25 or conditional Kcnq2 knockout mice that show premature death due to seizures, 26 these
Kv7.2(S559A) knock-in mice showed normal growth with no premature death ( Figure S1 ). We examined basic electrophysiologic properties of primary cultured cortical neurons from Kv7.2(S559A) mice. To minimize rundown of the M-current during measurements, we used the amphotericin B perforated patch technique. Cells were held at a holding potential of −30 mV to inactivate most voltage-gated channels, and 1-second test potentials between −120 mV and +10 mV were applied to measure remaining noninactivating currents ( Figure 1B) . Obtained I-V responses from neurons were almost identical between wild-type and Kv7.2(S559A) mice ( Figure 1B,C) . In addition, there were no differences in membrane capacitances (46.5 ± 3.3 pF for wt [n = 27], 46.2 ± 4.0 pF for Kv7.2(S559A) [n = 24]) or input resistance near the resting membrane potential at −70 mV (218 ± 18 MΩ for wt, 201 ± 20 MΩ for K7.2 (S559A)). These results suggest that expression of Kv7.2(S559A) subunits did not cause significant changes in the biophysical properties of these neurons.
We next focused on the M-current and M-current suppression in cultured cortical neurons. Cells were held at −30 mV and conductance was monitored by a 500-msec step hyperpolarization to −50 mV. After stable recordings were established, 0.3 μmol/L oxotremorine-M (oxo-M) was applied to measure M-current suppression, followed by 10 μmol/L XE991 for full inhibition of the M-current (Figure 1D ). M-current was measured as XE991-sensitive standing current at −30 mV because XE991 is a Kv7 channel selective inhibitor; 0.3 μmol/L oxo-M suppressed the M-current to 56.7 ± 4.3% (n = 9) in neurons from wildtype control. In contrast, neurons from Kv7.2(S559A) showed little M-current suppression, and M-currents were preserved at 89.1 ± 6.3% (n = 10) in the presence of oxo-M (P < 0.01, Mann-Whitney test). Similar results were obtained from SCG neurons (Figure S1F,G) . Next, doseresponse experiments were conducted to evaluate M-current suppression at various agonist concentrations ( Figure 1E ). The dose-response curve showed an IC 50 of 0.32 ± 0. 02 μmol/L and I min of 0.1 ± 0.01 for wild-type control. In contrast, that from Kv7.2(S559A) mice showed an IC 50 of 1.28 ± 0.08 μmol/L and I min of 0.35 ± 0.01. These results suggest that the M-current in Kv7.2(S559A) mice requires higher concentration of oxo-M for suppression with an increased resistant fraction. These results indicate that we have generated Kv7.2 mutant knock-in mice that have diminished M-current suppression while retaining normal basal M-current activity.
| Protective phenotype of Kv7.2(S559A) mice against chemoconvulsant-induced seizures
Because a muscarinic agonist, pilocarpine, is widely used to induce experimental seizures, 27 we first tested pilocarpine-induced seizures to examine whether diminished M-current suppression has any anticonvulsaant effect. In wild-type mice, pilocarpine injection (289 mg/kg pilocarpine, ip) caused persistent behavioral seizures reaching to the maximal stage 5 in a modified Racine scale, whereas the maximal seizure stage for most of the homozygous Kv7.2(S559A) mice tested peaked at stage 3 (P < 0.01, Figure 2 ). Mortality in pilocarpine-injected mice was 3/9 for wild-type mice, and 0/5 for Kv7.2(S559A) mice. To examine whether this resistance to pilocarpine is due to the preserved M-current during seizures, we administered XE991 (2 mg/kg, ip) 30 minutes after pilocarpine injection. After administration of XE991 to Kv7.2(S559A) mice, pilocarpine-induced seizures reached stage 5, equivalent to that of wild-type control, and the effect gradually diminished after 1 hour ( Figure 2B ,C).
To examine whether the resistance of Kv7.2(S559A) mice to chemoconvulsants is limited to seizures induced by muscarinic agonists, we next tested kainate. Kainate receptors are ionotropic receptors that depolarize membrane potentials in neurons and are used widely to induce experimental seizures. 28 Administration of kainate (30 mg/kg, sc)
induced severe seizures in wild-type control mice, most of which reached the maximal seizure stage 6, while inducing milder stage 3 seizures in Kv7.2(S559A) mice, as shown in Figure 2D (P < 0.001). In addition, mortality was 8/12 for wild-type and 0/13 for Kv7.2(S559A) mice (P < 0.001, 2-tailed Fisher's exact test). Similar to pilocarpine-induced seizures, resistance to kainate was transiently abolished by administration of XE991 ( Figure 2E,F) . These results suggest that disruption of M-current suppression by Kv7.2 (S559A) mutant channels attenuates behavioral seizures and increases survival rate in these chemoconvulsantinduced seizures. We previously demonstrated that preservation of the M-current contributes to the nonacute anticonvulsant effect of VPA, 19 theoretically through a mechanism similar to that of the Kv7.2(S559A) mutation. Therefore, we tested whether VPA effects were occluded in Kv7. Figure 3A) . In contrast, diazepam (5 mg/kg, ip), which targets γ-aminobutyric acid (GABA) receptors, further suppressed behavioral seizures in Kv7.2(S559A) mice ( Figure 3B,C) . These results suggest that the Kv7.2(S559A) mutation and VPA treatment use the same pathway for their anticonvulsant effects.
| Effects of the Kv7.2(S559A) mutation against seizure-induced neuronal damage and epileptogenesis
Our results so far indicate that preserved Kv7.2 channel activity by Kv7.2(S559A) mutation has anticonvulsant effects. Another important question is whether disruption of M-current suppression is involved in epileptogenesis.
One hypothesis for epileptogenesis is that brain damage caused by an initial severe seizure induces remodeling of neuronal circuits, which leads to spontaneously recurrent seizures. 29 Pilocarpine-induced status epilepticus was used for this experiment, since C57BL/6 mice are resistant to neurodegeneration after kainate-induced seizures. 30 We used the condition shown in Figure 2 with XE991 injection (2 mg/kg, ip) at 30 minutes after pilocarpine administration to deliver equivalent status epilepticus in Kv7.2(S559A) and wild-type mice ( Figure S2 ). To evaluate whether both groups underwent equivalent neural excitation, induction of c-Fos was examined by immunohistochemistry in the hippocampus (Figure 4) . In wild-type mice, administration of pilocarpine as well as pilocarpine+XE991 induced significant c-Fos expression in the CA1 region and the dentate gyrus ( Figure 4 ). In contrast, pilocarpine administration alone did not induce c-Fos expression in Kv7.2(S559A) mice ( Figure 4 ) as was predicted from milder seizures (Figure S2) . In contrast, XE991 administration during pilocarpine-induced seizures exacerbated seizures in Kv7.2 (S559A) mice ( Figure S2 ) and induced c-Fos expression equivalent to that of wild-type mice with status epilepticus (Figure 4) . For both genotypes, c-Fos-positive cells were predominantly pyramidal neurons in the CA1 region, and those in the dentate gyrus were found both in the granule cell layer and in the hilus (Figure 4) . A separate cohort was used to determine seizureinduced neurodegeneration. Neuronal damage was assessed by FJC staining 2 days after initial status epilepticus using the same pilocarpine+XE991 protocol ( Figure S2 ). We found prominent FJC-positive neurons in various brain regions including the CA1 region and the dentate gyrus of the wild-type control ( Figure 5 and Figure S3 ). The majority of FJC-positive cells were pyramidal neurons in the CA1 region and neurons in the hilus of the dentate gyrus ( Figure 5 ). Of interest, even though granule neurons showed apparent c-Fos induction (Figure 4) , there was minimal FJC staining in granule neurons ( Figure 5 ). For Kv7.2(S559A) mice, we detected nominal FJC-positive neurons throughout the brain including these 2 brain regions, which were not significantly different from the negative control ( Figure 5 and Figure S3 ). These results suggest that the Kv7.2(S559A) mutation has neuroprotective effects against pilocarpine-induced status epilepticus. Spontaneous recurrent seizures after pilocarpine-induced status epilepticus are used widely as a model for temporal epilepsy. 27 Therefore, we examined the occurrence of spontaneously recurrent seizures in wild-type and Kv7.2 (S559A) mice 3 weeks after pilocarpine-induced status epilepticus using the pilocarpine+XE991 protocol. Cumulative seizure stage suggested that both groups underwent equivalent status epilepticus ( Figure S2 ). Three weeks later, we examined for the occurrence of spontaneous seizures during 3-hour observation periods for 15 consecutive days.
In the wild-type control mice, we detected recurrent behavioral seizures on 5.7 ± 0.7 days in 10 of 11 mice (Figure 6A) , which lasted 70 ± 0.2 seconds. The remaining wild-type mice showed seizures only during one observation period. In contrast, Kv7.2(S559A) mice showed no recurrent spontaneous seizures (0/10, P < 0.0001, MannWhitney test, Figure 6A ). Only a single seizure episode was detected in one Kv7.2(S559A) mouse, which lasted 125 seconds. To examine epileptogenic changes in these mice, we conducted GAD67 immunostaining, since reduction in GABAergic neurons is implicated in epileptogenesis. 24 GAD67 immunoreactivity was reduced in status epilepticus-experienced wild-type mice compared to naive control wild-type mice ( Figure 6B-D) . In contrast, such a reduction was not observed in status epilepticus-experienced Kv7.2(S559A) mice ( Figure 6B-D) . Spontaneously recurrent seizures and GAD67 immunoreactivity suggest epileptogenic changes were averted in Kv7.2(S559A) mice.
| DISCUSSION
We generated Kv7.2(S559A) knock-in mice that exhibit normal growth and no premature death, suggesting that Mcurrent suppression is not required for basic life-supporting behaviors. Furthermore, we demonstrated that Kv7.2 (S559A) knock-in mice have milder seizures in both kainate-and pilocarpine-induced seizure models. In addition, mortality in both chemoconvulsant-induced seizure models was suppressed in Kv7.2(S559A) mice in the conditions used in this study. Because XE991 administration exacerbates seizures in Kv7.2(S559A) mice to the level of wildtype mice, resistance to chemoconvulsant-induced seizures in Kv7.2(S559A) mice is most likely attributed to preservation of the M-current during seizures. This result supports our view that the anticonvulsant mechanism of action for VPA is critically dependent on this phospho-acceptor residue during seizures.
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Because M-current regulates the tone of neural firing, it may not be surprising that M-current suppression facilitates neural firing during seizures. However, whether prompt restoration of M-current after seizures has any therapeutic benefits is an open question. XE991 selectively exacerbates seizures in Kv7.2(S559A) mice, which lasts approximately 1 hour, as shown in Figure 2 . This duration of XE991 effect is consistent with published pharmacokinetic studies. 31, 32 In addition, our recent study shows that XE991 is an irreversible inhibitor for Kv7 channels, suggesting that recovery is due to removal of XE991 from the system rather than washout of XE991 from Kv7 channels. 33 Our FJC staining results suggest that recovery of M-current after XE991 inhibition, which occurs after status epilepticus, is still sufficient to prevent neuronal degeneration. Nonetheless, the neuroprotective effects in Kv7.2(S559A) mice were unexpected because we initially assumed that postseizure neuronal degeneration was due to excitotoxicity as a result of status epilepticus. One caveat to this conclusion is whether Kv7.2(S559A) mice indeed underwent status epilepticus equivalent to that of wild-type control mice. However, we think that it is highly likely that both groups experienced equivalent status epilepticus for the following reasons: (1) c-Fos immunohistochemistry showed Figure S2 ). In contrast, our experimental design is not able to elucidate whether M-current suppression after status epilepticus takes the form of sustained suppression or repetitive suppression. In addition, it will be important to determine the critical period of this protective effect. These issues should be addressed in future studies. Our results provide evidence for the involvement of M-current suppression during seizure; however, this study presents some limitations to be addressed. (1) Characterization of the M-current was conducted in cultured neurons; use of brain slice electrophysiology will provide an environment more closely resembling neuromodulation in vivo. [34] [35] [36] (2) Although there is an inherent lack of behavioral seizures in Kv7.2(S559A) mice using the pilocarpine model of acquired epilepsy, future inclusion of electroencephalography (EEG) will provide more definite proof of the absence of ictal activities following status epilepticus. (3) The timing and extent of M-current suppression in vivo are currently unknown, which provides future direction for determining the aforementioned critical period of M-current suppression responsible for its contribution to epileptogenesis. In summary, M-current suppression not only exacerbates seizures but also contributes to neuronal degeneration and epileptogenesis in mouse. Therefore, prompt restoration of Kv7.2 channel function after seizures may provide long-term therapeutic benefits and should be explored further.
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